EUVIMEDEUVIMED entdecken
Crossref

Lung-Accumulating Mucin 5AC Silencing by Noninflammatory Lipid Nanoparticles for Asthma Treatment

Zhiqiang Zhao, Xinzhu Shan, Weixue Wang, Changdi Cao, Dian Chen, Lanhe Chu, Yan Zeng, Yunxuan Liu, Yue Yang, Yun Wu, Yanping Zhao, Junhe Chen und 7 weitere

ACS Nano · 24.03.2026 · 20 (11) · 9105-9121

DOI: 10.1021/acsnano.5c16693 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 09.03.2026. Verfasst von Zhiqiang Zhao und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China. Hauptthemen laut MEDLINE: Asthma, Nanoparticles, Mucin 5AC, RNA, Small Interfering. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Liaoning Revitalization Talents Program, Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaNanoparticlesMucin 5ACRNA, Small InterferingLipidsGene SilencingLungAnimalsMiceHumansFemaleLiposomes

Stichwörter der Autor:innen

MUC5ACasthmainflammatory side effectslipid nanoparticlesiRNA delivery

Substanzen

Mucin 5ACRNA, Small InterferingLipidsLipid NanoparticlesLiposomes

Autor:innen und Institutionen

  • Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China.
  • State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
  • Beijing Key Laboratory of Molecular Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
  • Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing 100191, China.
  • Beijing Tide Pharmaceutical Co., Ltd., Beijing 100176, China.
  • University of North Carolina, Chapel Hill, North Carolina 27599, United States.

ORCID-Profile: Xueguang Lu, Lei Miao, Cong Luo

Förderung

  • National Key Research and Development Program of China
  • Liaoning Revitalization Talents Program
  • Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park
  • Natural Science Foundation of Beijing Municipality
  • National Natural Science Foundation of China
  • Project of China-Japan Joint International Laboratory of Advanced Drug Delivery System Research and Translation of Liaoning Province

Zitieren

APA

Zhao, Z., Shan, X., Wang, W., Cao, C., Chen, D., Chu, L., Zeng, Y., Liu, Y., Yang, Y., Wu, Y., Zhao, Y., Chen, J., Wang, Z., Liu, X., Chen, Y., Lu, X., Zhou, J., Miao, L., & Luo, C. (2026). Lung-Accumulating Mucin 5AC Silencing by Noninflammatory Lipid Nanoparticles for Asthma Treatment. ACS Nano, 20(11), 9105-9121. https://doi.org/10.1021/acsnano.5c16693

Vancouver

Zhao Z, Shan X, Wang W, Cao C, Chen D, Chu L, et al. Lung-Accumulating Mucin 5AC Silencing by Noninflammatory Lipid Nanoparticles for Asthma Treatment. ACS Nano. 2026;20(11):9105-9121. doi:10.1021/acsnano.5c16693

BibTeX
@article{Zhao2026,
  author = {Zhao, Zhiqiang and Shan, Xinzhu and Wang, Weixue and Cao, Changdi and Chen, Dian and Chu, Lanhe and Zeng, Yan and Liu, Yunxuan and Yang, Yue and Wu, Yun and Zhao, Yanping and Chen, Junhe and Wang, Zhenfan and Liu, Xiaojuan and Chen, Yahong and Lu, Xueguang and Zhou, Jian and Miao, Lei and Luo, Cong},
  title = {Lung-Accumulating Mucin 5AC Silencing by Noninflammatory Lipid Nanoparticles for Asthma Treatment},
  journal = {ACS Nano},
  year = {2026},
  volume = {20},
  number = {11},
  pages = {9105--9121},
  doi = {10.1021/acsnano.5c16693}
}
Kostenlos starten →